Efficacy of albumin use in decompensated cirrhosis and real‐world adoption in Australia

Documenti analoghi

• Home Management of Refractory Ascites in Decompensated Cirrhosis With Long‐Term Abdominal Drains, a Pilot Study
  di: Jeyamani Ramachandran, et al.
  Pubblicazione: (2025)
• Safety of DOACs in patients with Child‐Pugh Class C cirrhosis and atrial fibrillation
  di: Mark Ayoub, et al.
  Pubblicazione: (2024)
• Clinical utility of C‐reactive protein‐to‐albumin ratio in the management of patients with inflammatory bowel disease
  di: Anke L Nguyen, et al.
  Pubblicazione: (2024)
• MELD3.0 is superior to MELDNa and MELD for prediction of mortality in patients with cirrhosis: An external validation in a multi‐ethnic population
  di: Hong‐Yi Lin, et al.
  Pubblicazione: (2024)
• Isolated Right Ventricular Metastasis of Hepatocellular Carcinoma: Clinical Findings and Histopathology of an Atypical Presentation
  di: Aaron Yee Shuen See, et al.
  Pubblicazione: (2024)